Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs

DA Dalwadi, L Ozuna, BH Harvey, M Viljoen… - Pharmacological …, 2018 - Elsevier
Efavirenz is a highly effective HIV-1 antiretroviral; however, it is also frequently associated
with neuropsychiatric adverse events (NPAE) that include abnormal dreams, sleep …

Polygenic risk scores for disease risk prediction in Africa: current challenges and future directions

S Fatumo, D Sathan, C Samtal, I Isewon, T Tamuhla… - Genome Medicine, 2023 - Springer
Early identification of genetic risk factors for complex diseases can enable timely
interventions and prevent serious outcomes, including mortality. While the genetics …

Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications

F Zhang, J Finkelstein - Pharmacogenomics and personalized …, 2019 - Taylor & Francis
Introduction Racial and ethnic categories are frequently used in pharmacogenetics literature
to stratify patients; however, these categories can be inconsistent across different studies. To …

Phage biobank: present challenges and future perspectives

RCY Lin, JC Sacher, PJ Ceyssens, J Zheng… - Current opinion in …, 2021 - Elsevier
After a century of use in human infection, the preparation and administration of therapeutic
bacteriophages (phages) still relies on ad hoc partnerships of researchers, biotech …

The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post …

MD Ritchie - Human genetics, 2012 - Springer
Pharmacogenomics is emerging as a popular type of study for human genetics in recent
years. This is primarily due to the many success stories and high potential for translation to …

[PDF][PDF] Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review.

EB Tata, MA Ambele, MS Pepper - Precision Medicine, 2020 - mdpi.com
Clinical research in high-income countries is increasingly demonstrating the
costeffectiveness of clinical pharmacogenetic (PGx) testing in reducing the incidence of …

Is universal health coverage the practical expression of the right to health care?

G Ooms, LA Latif, A Waris, CE Brolan… - … International Health and …, 2014 - Springer
Abstract The present Millennium Development Goals are set to expire in 2015 and their next
iteration is now being discussed within the international community. With regards to health …

Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects

A Matimba, J Del-Favero, C Van Broeckhoven… - Human genomics, 2009 - Springer
Pharmacogenetics enables personalised therapy based on genetic profiling and is
increasingly applied in drug discovery. Medicines are developed and used together with …

Pharmacokinetics of tamoxifen and its major metabolites and the effect of the African ancestry specific CYP2D6* 17 variant on the formation of the active metabolite …

CR Kanji, G Nyabadza, C Nhachi… - Journal of personalized …, 2023 - mdpi.com
Tamoxifen (TAM) is widely used in the treatment of hormone receptor-positive breast cancer.
TAM is metabolized into the active secondary metabolite endoxifen (ENDO), primarily by …

Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation

L Warnich, BI Drogemoller, MS Pepper… - Current …, 2011 - ingentaconnect.com
South Africa, like many other developing countries, stands to benefit from novel diagnostics
and drugs developed by pharmacogenomics guidance due to high prevalence of disease …